Family Medicine Doctors in John Day, OR Accepting Medicare
6 Family Medicine doctors found. Showing 1 - 6
 Caitlin R Maccoun, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 180 Ford Rd, John Day, OR 97845 Phone: 206-386-6111 |
 Brian Jennings, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 180 Ford Rd, John Day, OR 97845 Phone: 541-575-0404 Fax: 541-575-1124 |
Robyn Jennings, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 180 Ford Rd, John Day, OR 97845 Phone: 541-575-0404 |
Emily A Lieuallen, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Strawberry Wilderness Clinic, 180 Ford Rd., John Day, OR 97845 Phone: 541-575-0404 Fax: 541-575-4158 |
Dr. Bennette Edward Norton Iii, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 180 Ford Road, John Day, OR 97845 Phone: 541-575-0404 Fax: 541-575-1124 |
Dr. Zachary Max Bailey, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 180 Ford Rd, John Day, OR 97845 Phone: 541-575-0404 Fax: 541-575-1124 |
News Archive
Targeting tumor behavior may find new anti-cancer agents
Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior. The agents target multiple genes associated with that behavior at one time.
New medical education portal - Lipoprotein Perspectives - launched
LipoScience, Inc., an in vitro diagnostic company advancing patient care by developing high value proprietary clinical tests using nuclear magnetic resonance (NMR) technology, announced the launch of Lipoprotein Perspectives - a medical education portal featuring experts in clinical and preventive cardiology, endocrinology, and lipidology - at www.lipoprotein.org.
NASDAQ Stock Market issues delisting notice to American Bio Medica Corporation
American Bio Medica Corporation (NASDAQ: ABMC) announced today that, on August 25, 2009, it received a delisting notice from the NASDAQ Stock Market, for failure to regain compliance with the minimum bid price requirement pursuant to Listing Rule 5550(a)(2).
PET scan shows promise in predicting patients with inoperable lung cancer
Advanced imaging with Positron Emission Tomography (PET) scan shows great promise in predicting which patients with inoperable lung cancer have more aggressive tumors and need additional treatment following standard chemotherapy/radiation therapy, according to new research recently published online in the Journal of Clinical Oncology.
Researchers simplify creation induced pluripotent stem (iPS) cells
Bryce Carey, an MIT graduate student working in the lab of Whitehead Member Rudolf Jaenisch, spearheaded the effort by joining in tandem the four reprogramming genes through the use of bits of DNA that code for polymers known as 2A peptides. Working with others in the lab, he then manufactured a so-called polycistronic virus capable of expressing all four reprogramming genes once it is inserted into the genomes of mature mouse and human cells.
› Verified 5 days ago